Report Highlights
The global market for western blotting is expected to grow from $1.5 billion in 2023 to over $2.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2023-2028.
Report Includes
- 47 data tables and 17 additional tables
- An overview of the global market for western blotting
- Analysis of global market trends, featuring historical revenue data for 2020 to 2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product, application, end user and geographical region
- Descriptions of concepts such as gel electrophoresis and antibody probing, and processes such as tissue preparation, protein transfer, blocking and antibody interactions
- Discussion of major application areas of western blotting technique such as disease diagnostics, agriculture, biomedical and biochemical research
- Assessment of processes such as protein separations and extraction of target proteins, and new imaging platforms such as fluorescent, multiplex and chemiluminescent western blotting techniques and their protocols
- Coverage of emerging technologies in western blotting market, recent developments, future opportunities, patent review, product pipelines and ESG trends
- Market share analysis of the key companies and coverage of mergers & acquisitions, joint ventures, collaborations and partnerships
- Profiles of leading market participants
Report Scope
The current report will provide detailed analysis of the Western blotting market. This report analyzes the market trends with data from 2020, estimates from 2022, projections of compound annual growth rates through 2028 (forecast period 2023-2028), and analysis of regional markets. This report will highlight the current and future market potential of Western blotting, and includes a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.
The scope of this report is segmented into product type, applications, end user, and region. Product type is further segmented into instruments and consumables. Instrument products are segmented into imagers, blotting systems, and gel electrophoresis instruments. Consumables are segmented into reagents, kits, and others. The applications are segmented into biomedical and biochemical research, disease diagnostics, agriculture, and others. The end users are segmented into academic and research institutes, pharmaceutical and biotech companies, diagnostic centers, and others.
A regional market analysis for Western blotting is also covered in this report. The market has been segmented into various significant geographies, including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. A detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within the regional segment. For market estimates, data will be provided for 2022 as the base year, with forecasts for 2023 and forecast value for 2028.
Report Synopsis
Report Metrics | Details | ||||||||
---|---|---|---|---|---|---|---|---|---|
Base year considered | 2022 | ||||||||
Forecast period considered | 2023-2028 | ||||||||
Base year market size | $1.4 billion | ||||||||
Market size forecast | $2.1 billion | ||||||||
Growth rate | CAGR of 7.6% from 2023-2028 | ||||||||
Units considered | $ Millions | ||||||||
Segments covered | By Product Type, Application, End User, and Region | ||||||||
Regions covered | North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA) | ||||||||
Key Market Drivers |
|
||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
Western blotting is the one of the most widely-used methods for protein identification and relative quantitation. This report will look at the application areas and market dynamics of western blotting market.
Report Includes
- An overview of the global market for western blotting and discussion on factors impacting this process
- Knowledge about processes like tissue preparation, proteins transfer, blocking and antibody interactions
- Description of concepts like gel electrophoresis and antibody probing
- Details of Lyme disease and HIV/AIDS and discussion on how it plays a major driving factor to the industry
- Discussion on major application areas of Western Blotting technique such as disease diagnostics, agriculture, biomedical & biochemical research
- Coverage of fluorescent, multiplex and chemiluminescent Western blotting techniques and description of their protocol
Related Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Global Markets for Research Antibodies
The global market for research antibodies is estimated to increase from $3.7 billion in 2023 to reach $5.8 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
Protein Sequencing: Global Market
The global market for protein sequencing should grow from $1.3 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 4.6% for the period of 2021-2026.
Biomarkers: Technologies and Global Markets
The global market for biomarkers should grow from $43.3 billion in 2020 to $92.1 billion by 2025, at compound annual growth rate (CAGR) of 16.3% for the period of 2020-2025.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More